CannabisNewsBreaks

MondayFeb 08, 2021 12:19 pm

CannabisNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Partners with Massive Media, GG Marketing LLC as Part of Strategic 2021 Sales and Marketing Plan

Green Hygienics (OTCQB: GRYN), an innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, has engaged Massive Media Inc. and GG Marketing LLC. Green Hygienics will work with Massive Media to refresh the GRYN brand; the partnership will include building a new corporate website. Green Hygienics will work with GG Marketing to establish sales and distribution. These two key partnerships are part of GRYN’s strategic sales and marketing plans for 2021. As part of those plans, the company is working to launch its 2021 sales and marketing initiatives along with…

Continue Reading

MondayFeb 08, 2021 11:13 am

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Releases Preliminary Revenue Numbers, Notes 714% Growth for Calendar Year

Grapefruit USA (OTCQB: GPFT), a premiere, fully licensed California-based cannabis company, announced its unaudited revenue results for calendar year 2020. The numbers indicate that Grapefruit totaled revenues of an estimated $3,672,353 for the year ended Dec. 31, 2020, which represents an increase of approximately $3,221,156 from 2019. The announcement noted that, based on those preliminary numbers, the company is reporting revenue growth of 714% in 2020. The company has spent the last year and a half focused on bringing its patented Hourglass(TM) topical THC/cannabinoid delivery cream to market. Demand for the disruptive product has been robust, the company reported, with…

Continue Reading

ThursdayFeb 04, 2021 3:26 pm

CannabisNewsBreaks – CannAssist International Corporation (CNSC) Pioneers Promising CiBiDinol Technology

CannAssist (OTCQB: CNSC), a biotechnological pharmaceutical and wellness company, believes that its proprietary CiBiDinol technology will be a game-changer. According to a recent article, “the company believes that the amount of CBD needed to achieve the targeted therapeutic effects can be reduced significantly, resulting in reduced costs for both manufacturers and consumers.” CBD-based products “reduce inflammation while providing pain relief.” They are also the preferred option because they are “a gentler way to relieve pain and reduce inflammation,” unlike mainstream pharmaceuticals that have dangerous toxicity levels. CiBiDinol’s high efficacy per dose was the subject of “testing conducted via third-party services…

Continue Reading

ThursdayFeb 04, 2021 2:40 pm

CannabisNewsBreaks – Gage Cannabis Co. Poised Amid Michigan’s 1st Anniversary of Recreational Marijuana Sales

Gage Cannabis, a leading vertically integrated cannabis operator currently focused exclusively on the Michigan market, is positioned for opportunity after the state recently celebrated its one-year anniversary of the legalization of recreational marijuana. A recent article discussing this reads, “Gage Cannabis has been able to partake in the region’s rapid growth trajectory as a by-product of the company’s aggressive expansion plan – one that has seen the opening of six medical or adult-use locations across the state, with a further 10+ locations slated to open in 2021. The company has also announced its intentions to raise up to $50 million…

Continue Reading

ThursdayFeb 04, 2021 2:09 pm

CannabisNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) Builds on Success, Launches into 2021 with Exciting Projects

Pac Roots (CSE: PACR), an innovative genetics-based cannabis company located in Canada, recently provided an update to investors and stakeholders following the first hemp harvest on its 100-acre site situated in British Columbia’s South Okanagan Valley. Pac Roots announced the remarkable success of its initial harvest, which yielded a quality far higher than expected. The company also announced that it would process and sell the entire >105,000-pound biomass to Speakeasy Cannabis Club (CSE: EASY).  A recent article covered this as well as the company’s low-cost production capabilities, which Pac Roots believes provide a sustainable competitive advantage and the ability to…

Continue Reading

ThursdayFeb 04, 2021 1:35 pm

CannabisNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Continues Build Out of Highly Differentiated Business Model

Green Hygienics Holdings (OTCQB: GRYN) ("GHH") is focused on quality cultivation and processing of industrial hemp as well as manufacturing of pharmaceutical-grade bioactive cannabinoids. On the heels of its first successful crop harvest and entry into the wholesale retail stage of development, the company has engaged the services of McAllister Garfield, PC, a top law firm in the industrial hemp space. Green Hygienics made the decision in anticipation of rapid growth in 2021. “When lawmakers tighten the belt on hemp regulations, Green Hygienics is positioning itself to be ahead of the curve and thrive,” said GRYN CEO Ron Loudoun in…

Continue Reading

ThursdayFeb 04, 2021 10:06 am

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces CannRX Biosciences Partnership

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a U.S.-based cannabis and hemp-branded products company, has entered into a partnership with CannRx Biosciences (“CannRx”). Based in Tel Aviv, CannRX is a leading Israeli cannabis firm focused on the development cannabis-based botanical medicine. The partnership involves using CannRx’s proprietary onset technology, CannTrap, which is a solid nano-particle, water-soluble technology that uses proteins to increase the bioavailability of cannabinoids and terpenes. CannRx works by replicating the body’s sophisticated, protein-based transport system to facilitate improved delivery of active compounds throughout the body; CannRx developed the technology for specific use with cannabinoids. The partnership calls for…

Continue Reading

WednesdayFeb 03, 2021 12:11 pm

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) to Hold Extraordinary Meeting of Debentureholders

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp-branded products company in the United States, has announced an upcoming shareholder meeting. The meeting, scheduled for 10 a.m. ET on Feb. 25, 2021, is an extraordinary meeting of holders of 8% unsecured convertible debentures that are due Feb. 28, 2021. Information containing detailed information regarding the amendments and resolutions to be considered during the meeting has been mailed to the company’s debentureholders of record. The meeting will be held virtually to maintain COVID-19 social distancing requirements; participants will be attending via a telephone conference. The announcement noted that the company’s…

Continue Reading

WednesdayFeb 03, 2021 11:50 am

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Publication of Article Led by CEO Dr. Roger McIntyre

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) today announced the publication of an article led by its CEO Dr. Roger McIntyre. The article, titled, “The Rapid Mood Screener (‘RMS’): a novel and pragmatic screener for bipolar I disorder,” is published at Taylor and Francis.com. "Timely and accurate diagnoses are precursors of good clinical outcomes in persons with treatment-resistant mood disorders, the high rate of missed bipolar disorder diagnosis is a critical unmet need," stated Dr. Roger McIntyre. "The Rapid Mood Screener provides a systematic approach to screening for bipolar disorder amongst all patients who present with depressive symptoms. It…

Continue Reading

WednesdayFeb 03, 2021 11:14 am

CannabisNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Signs Production Agreement with Applied Pharmaceutical Innovation

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, announced that it has signed an agreement with Applied Pharmaceutical Innovation. A not-for-profit institution at the University of Alberta, Applied supports translational drug development for industry and innovators. XPhyto’s psychedelic pharmaceutical production agreement calls for the synthesis of pharmaceutical-grade psychedelic compounds and the development of the standard operating procedures required to obtain regulatory approval for the commercial production process. As part of its psychedelic pharmaceutical program, XPhyto needs industrial-scale production of standardized active pharmaceutical ingredients. This agreement is part of that strategic…

Continue Reading